Research, Development and Production to Support Clinical Trials for HIV Vaccines
Research, Development and Production to Support Clinical Trials for HIV Vaccines
支持 HIV 疫苗临床试验的研究、开发和生产
批准号：
9368890
负责人：
DAVID LINDSAY
金额：
$530.0万
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
项目状态：
已结题
起止时间：
2016-09-16 至 2021-09-15
关键词：
ClinicalClinical ResearchClinical TrialsCommunicable DiseasesDevelopmentDisease OutbreaksHIVHIV vaccineMissionNational Institute of Allergy and Infectious DiseasePreclinical TestingProductionServicesTestingclinical materialpreclinical studyprogramsresearch and developmentresearch clinical testingvaccine candidate
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of HIV vaccines. The VRC seeks to facilitate development of HIV vaccine products leading to protection against HIV. The objectives is to develop and manufacture clinical materials, and carry out preclinical and non-clinical testing of HIV vaccines required for advancement of products to clinical studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID-VRC- Rapid Manufacturing Response
-
批准号：10722383
-
项目类别：
-
资助金额：$982.24万
-
财政年份：2022
-
负责人：DAVID LINDSAY
-
依托单位：
NIAID- VRC- Research, Development, and Production to Support Clinical Trials for HIV Vaccines.
-
批准号：10722425
-
项目类别：
-
资助金额：$1014.32万
-
财政年份：2022
-
负责人：DAVID LINDSAY
-
依托单位：
NIAID- VRC HIV mAb-Research, Development, and Production to Support HIV Monoclonal Antibody Development
-
批准号：10722410
-
项目类别：
-
资助金额：$1314.53万
-
财政年份：2022
-
负责人：DAVID LINDSAY
-
依托单位：
Anti-HIV Broadly Neutralizing Monoclonal Antibody (bnAbs) Drug Substance (DS) Clinical Trial Material Production and Release
-
批准号：10025661
-
项目类别：
-
资助金额：$589.77万
-
财政年份：2018
-
负责人：DAVID LINDSAY
-
依托单位：
海外基金
